First-stage palliation of complex univentricular cardiac anomalies in older infants

B W Duncan1, G L Rosenthal, T K Jones

  • 1Department of Pediatrics, Children's Hospital and Regional Medical Center, and the University of Washington School of Medicine, Seattle, USA. duncanb@ccf.org

Insights

First-stage surgical palliation for infants over 30 days with complex congenital heart defects shows comparable outcomes to neonates. Utilizing a larger shunt may improve results for these challenging pediatric cardiac cases.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Surgery
  • Neonatal Intensive Care

Background:

  • Historically, infants older than 30 days with complex cardiac anomalies have had poor outcomes following first-stage palliation.
  • This study addresses the outcomes of a policy extending first-stage palliation to all eligible patients regardless of age.

Purpose of the Study:

  • To evaluate the effectiveness and outcomes of first-stage surgical palliation in infants older than 30 days with complex congenital heart disease.
  • To determine if outcomes in this older infant group are comparable to those typically seen in neonates.

Main Methods:

  • Retrospective review of patients older than 30 days who underwent first-stage palliation.
  • Procedures included Norwood or Damus-Kaye-Stancel with a modified Blalock-Taussig shunt.
  • Subsequent procedures like bidirectional Glenn and Fontan reconstruction were analyzed.

Main Results:

  • Nine patients (median age 67 days) with conditions like hypoplastic left heart syndrome underwent palliation, with all surviving the initial operation.
  • Eight patients proceeded to bidirectional Glenn, with 6 survivors.
  • Two survivors have completed Fontan reconstruction, and four are awaiting it.

Conclusions:

  • First-stage surgical palliation is feasible and yields comparable results in older infants (over 30 days) with complex univentricular cardiac malformations compared to neonates.
  • The use of a larger modified Blalock-Taussig shunt may be a contributing factor to the improved outcomes observed in this cohort.
Abstract